SF Healthcare Week: Soleno Therapeutics' Chairman & CEO Anish Bhatnager discusses the launch of its Prader-Willi syndrome therapy VYKAT XR

from BiotechTV - News · host BiotechTV

He describes the launch, physician and patient feedback, and responds in his own words to short seller criticism.

Episode metadata supplied by the publisher feed · Published Jan 15, 2026

Embed this episode

Attribution link and audio player

Ready to play

SF Healthcare Week: Soleno Therapeutics' Chairman & CEO Anish Bhatnager discusses the launch of its Prader-Willi syndrome therapy VYKAT XR

0:00 10:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 10 minutes long.

This episode was published on January 15, 2026.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!